AbbVie Inc. (NYSE:ABBV)

Merger

Baxter Split-Up, a Page From Abbott’s Playbook

Baxter International Inc. (NYSE: BAX) is taking an activist investor role of its own. The health care company has announced that it is splitting itself into two separate companies, in ...
Read Full Story »
145922793

Jefferies’ Cheapest Health Care Stocks to Buy

With the beating the market took Thursday, many investors are starting to get a little worried that a major correction might be right around the corner. With the first quarter ...
Read Full Story »
health care

Merrill Lynch’s Top Health Care Stocks to Buy Now

Very quietly, while momentum stocks zoom up and down, one sector has made an almost stealth like move and is leading the S&P 500 so far this year. With the ...
Read Full Story »
investor research

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

With U.S. interest rates set to rise, concerns of a slowdown in the Chinese economy and the devaluation of several emerging market (EM) currencies, those markets are facing a rocky ...
Read Full Story »
Wall St Bull statue

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

2014 is upon us, and that means that investors have started positioning their portfolios for the year ahead. 24/7 Wall St. reviews many analyst calls each day in order to ...
Read Full Story »
goldman sachs

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

It is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews vast numbers of research reports looking for the best stocks ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

Stocks have finally shown that they can drop again, and Tuesday is looking a tad soft so far. After gains of well over 20% in the DJIA and S&P 500 ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More

We are in the thick of earnings season, a deal was made in D.C. and stocks are challenging new all-time highs almost daily. So how do investors know which stocks ...
Read Full Story »
IPO

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

The saying is that if there is a trading strategy, then there is an ETF strategy for that as well. Now the markets are getting a new exchange-traded fund strategy ...
Read Full Story »
Pills

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

The drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week's government shutdown and impending debt ceiling weighed heavily on biotech stocks. Credit ...
Read Full Story »
Merger

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

When the markets go through periods of great gains, it is not uncommon to see companies start to take more radical efforts to increase their total return for shareholders. Some ...
Read Full Story »
biotech

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Investors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the ...
Read Full Story »
Pills

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

As the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their coverage universe to find ...
Read Full Story »
Pills

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

One of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for ...
Read Full Story »
biotech

AbbVie Reports First Earnings Since IPO

AbbVie Inc. (NYSE: ABBV) reported first-quarter 2013 results before markets opened this morning. The pharmaceutical research firm posted adjusted diluted earnings per share (EPS) of $0.68 on revenues of $4.33 ...
Read Full Story »